Narcolepsy Drugs Market Analysis, Size, Share | Global Report 2022-2027


Narcolepsy Drugs Market Analysis, Size, Share | Global Report 2022-2027

The latest research study by IMARC Group, “Narcolepsy Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” o

How to Grow Your Twitch Following: A Comprehensive Guide for Content Creators
Blunder People Do While Choosing Airport Transportation Services
Water Electrolysis Market 2022 Global Trends, Demand, Segmentation and Opportunities Forecast To 2030

The latest research study by IMARC Group, “Narcolepsy Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” offers a comprehensive analysis of the industry, which comprises insights on global narcolepsy drugs market analysis.  The global narcolepsy drugs market size reached US$ 2.84 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.5 Billion by 2027, exhibiting a CAGR of 7.70% during 2022-2027.

Narcolepsy Drugs Industry Outlook:

Narcolepsy drugs represent the pharmaceutical medicines used for the treatment of chronic sleep disorders that are characterized by cataplexy or sudden loss of muscle strength, excessive daytime sleepiness (EDS), sleep paralysis, hallucinations, fragmented sleep, insomnia, etc. Additional symptoms may include blurred vision, automatic behaviors without conscious awareness, double vision or droopy eyelids, disturbed mental functioning, etc. Furthermore, patients suffering from narcolepsy tend to sleep the same number of hours per day as normal individuals; however, sleep quality tends to be poorer. Some of the commonly utilized narcolepsy drugs are sodium oxybate, central nervous system stimulants, selective serotonin reuptake inhibitors, tricyclic antidepressants, etc. They assist in improving wakefulness in adult patients and minimizing sleepiness, hallucinations, cataplexy, etc.

Request for a Free Sample Copy of This Report:

Market Trends:

The growing prevalence of sleep-related disorders is primarily driving the narcolepsy drugs market. Additionally, the rising consumer awareness towards the availability of various treatment alternatives is further catalyzing the market growth. Besides this, continuous improvements in the diagnostic technologies for narcolepsy are acting as significant growth-inducing factors.

Moreover, the expanding geriatric population, who are more susceptible to such ailments, and extensive R&D activities in the field of neurology are also positively influencing the global market. Apart from this, the leading manufacturers are developing variants with reduced side effects and long-term benefits, which is anticipated to fuel the narcolepsy drugs market over the forecasted period.

Narcolepsy Drugs Market Report Scope
Report Coverage Details
Market size value in 2021 US$ 2.84 Billion
Market forecast in 2027 US$ 4.5 Billion
Growth Rate CAGR of 7.70% from 2022 to 2027
Base year for estimation 2021
Historical data 2016-2021
Forecast period 2022-2027
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Type, disease Type, Therapeutic Type and Region
Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,
Customization preview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Key Market Segmentation:

The report has been segmented the market into following categories:

Breakup by Type:

  • Narcolepsy with Cataplexy
  • Narcolepsy without Cataplexy
  • Secondary Narcolepsy

Breakup by Disease Type:

  • Daytime Extreme Sleepiness
  • Cataplexia
  • Others

Breakup by Therapeutic Type:

  • Sodium Oxybate
  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Selective Serotonin Reuptake Inhibitor
  • Others

Breakup by Geography:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for 10% free customized report:

List of Key Companies Covered in this Market Report:

The major players in the market are Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

Browse Other Report by IMARC Group:

Thermoplastic Polyurethane Market –

IoT In Construction Market –

Industrial Hearables Market –

Human Identification Market –

Memristor Market –

Note: We are updating our reports, if you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

About IMARC Group:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

Company Name: IMARC Group
Contact Person: Elena Anderson
Phone: +1-631-791-1145
Address: 134 N 4th St.
City: Brooklyn
State: NY
Country: United States